The short answer

For most people paying cash in 2026, a brand-name GLP-1 through a telehealth platform runs roughly $150–$500 a month, once you use the manufacturer’s own savings program rather than list price. List price without any savings program or insurance is much higher — often $1,000+ a month. Insurance coverage varies enormously by plan and diagnosis, and can bring costs to $25–150/month or less for people who qualify. There is no single “GLP-1 price” — what you pay depends on which drug, whether you’re insured, and which savings program you use.

The breakdown by payment path

• List price, no insurance or savings program. Branded semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) list prices generally sit in the $1,000–$1,400/month range. Almost nobody actually pays this — it’s the starting number before any program is applied.
• Manufacturer cash-pay programs. Novo Nordisk’s NovoCare program has offered Wegovy in tiers roughly $149–$399/month depending on dose, and Eli Lilly’s LillyDirect has offered Zepbound roughly $299–$499/month depending on dose and vial vs. pen format. These programs are for people without insurance coverage for the drug and change their pricing periodically — confirm the current tier directly with the manufacturer.
• Discount-card pricing. Pharmacy discount programs have offered introductory cash pricing as low as roughly $199/month for injectable Ozempic or Wegovy through partnered telehealth pathways — again, promotional and subject to change.
• Insured. With commercial insurance that covers the drug for an approved indication, copays can be dramatically lower — plan-dependent savings cards have brought some patients to $0–$25 per fill. The catch is prior authorization: many plans require documentation of BMI thresholds or a related diagnosis, and some employer plans exclude weight-loss GLP-1s entirely regardless of medical necessity.
• Telehealth platform bundles. Beyond the drug cost itself, telehealth platforms typically charge for the clinical visit and ongoing program — often bundled into an all-in monthly figure. This bundle usually includes the consult, prescription management, and check-ins, separate from whatever the pharmacy charges for the medication itself.

What actually moves the price

• Which drug and which dose. Higher maintenance doses generally cost more than starting doses within the same manufacturer program.
• Vial vs. pen/auto-injector. Some manufacturer programs price a single-dose vial lower than the multi-dose pen format for the same drug.
• Insurance and prior authorization. Coverage for weight-management use specifically (versus diabetes) is inconsistent across plans, and a diagnosis code that supports medical necessity often determines whether a plan will cover it at all.
• Whether you’re on a manufacturer savings program vs. paying a pharmacy directly. The gap between list price and a manufacturer’s own cash-pay tier is the single biggest lever most patients have.

Red flags to watch for

• Prices that seem far below every manufacturer or discount-card benchmark above, especially for a supposedly brand-name product — that’s a signal to check what you’re actually being sold.
• Any seller offering semaglutide or tirzepatide with no prescription requirement at any price.
• Subscription pricing that doesn’t clearly separate the medication cost from the platform/consult fee, making it hard to compare against a manufacturer’s direct pricing.

The next step

Before committing to a platform, it’s worth asking directly: which drug and dose is priced, is that the manufacturer’s savings-program price or list price, and does insurance apply. A licensed provider or telehealth platform’s billing team can walk through your specific coverage. For how the prescribing process itself works, see GLP-1 telehealth: how it works, for the current compounding landscape see compounded vs. brand-name semaglutide in 2026, and for the broader regulatory picture see the live legal status tracker.

Sources

• GoodRx — “GoodRx Launches New $39/Month Weight Loss Telemedicine Subscription… $199/Month Introductory Cash Price for Ozempic and Wegovy”
• GoodRx — “How Much Does Zepbound (Tirzepatide) Cost Without Insurance?”
• FDA — “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize”

Educational content only — not medical advice, and not a guarantee of any specific price. Prices change frequently; confirm current pricing directly with the manufacturer, pharmacy, or your insurance plan.

← All articles